Dougherty & Co began coverage on shares of R1 RCM (NASDAQ:RCM) in a research note released on Friday morning, Briefing.com Automated Import reports. The brokerage issued a buy rating and a $15.00 target price on the healthcare provider's stock. Several other analysts have also recently weighed in on the company. Robert W. Baird set a [...]